Loading clinical trials...
Loading clinical trials...
Benign paroxysmal positional vertigo (BPPV) represents the most common cause of labyrinthine vertigo with a lifetime prevalence of 2.4 percent. Onset is most common between the fifth and seventh decad...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Haukeland University Hospital
NCT06725966 · Benign Paroxysmal Positional Vertigo, Personalized Medicine
NCT05424302 · Peripheral Vestibular Disorder, Benign Paroxysmal Positional Vertigo, and more
NCT06314581 · Benign Paroxysmal Positional Vertigo
NCT07111000 · Benign Paroxysmal Positional Vertigo (BPPV)
NCT07075289 · Benign Paroxysmal Positional Vertigo (Disorder)
Haukeland University Hospital
Bergen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions